115 related articles for article (PubMed ID: 21801844)
1. An ex vivo standardized assay to measure human platelet cGMP.
di Villa Bianca Rd; Mitidieri E; Mirone V; Fusco F; Imbimbo C; Cirino G; Sorrentino R
J Pharmacol Toxicol Methods; 2011; 64(2):164-7. PubMed ID: 21801844
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
5. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
6. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
8. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway.
Branka JE; Vallette G; Jarry A; Laboisse CL
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):521-4. PubMed ID: 9163347
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
14. Biphasic effects of nitric oxide on calcium influx in human platelets.
Blackmore PF
Thromb Res; 2011 Jan; 127(1):e8-14. PubMed ID: 21056902
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma.
Jonasson S; Hedenstierna G; Hjoberg J
J Appl Physiol (1985); 2010 Aug; 109(2):521-31. PubMed ID: 20538845
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
17. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the glutamate-induced K(+) current in identified Onchidium neurons by nitric oxide donors.
Sawada M; Ichinose M; Anraku M
J Neurosci Res; 2000 Jun; 60(5):642-8. PubMed ID: 10820435
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide modulates ionic transport in the isolated intestine of the eel, Anguilla anguilla.
Trischitta F; Pidalà P; Faggio C
Comp Biochem Physiol A Mol Integr Physiol; 2007 Oct; 148(2):368-73. PubMed ID: 17604669
[TBL] [Abstract][Full Text] [Related]
20. Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade.
Levy D; Strassman AM
J Neurophysiol; 2004 Aug; 92(2):766-72. PubMed ID: 15056690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
